Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Mitsuyasu

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Current Opinion in HIV and AIDS|March 5, 2013
Curing HIV: lessons from cancer therapyRonald Mitsuyasu
The Journal of Infectious Diseases|May 10, 2002
Immune therapy: non-highly active antiretroviral therapy management of human immunodeficiency virus-infected patientsRonald Mitsuyasu
Current Opinion in Oncology|July 16, 2011
HIV-associated multicentric Castleman diseaseDeepa Reddy, Ronald Mitsuyasu
Current Opinion in HIV and AIDS|October 28, 2010
Cancer biomarkers in HIV patientsRichard F Ambinder, Kishor Bhatia, Otoniel Martinez-Maza, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2004
Anemia in HIV infection: clinical impact and evidence-based management strategiesPaul A Volberding, Alexandra M Levine, Douglas Dieterich, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 5, 2011
A randomized trial of interleukin-2 during withdrawal of antiretroviral treatmentRonald J Bosch, Richard B Pollard, Alan Landay, et al.
AIDS Research and Therapy|August 7, 2010
Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG Protocol A5051, a rollover trial of ACTG Protocol A328)Ronald J Bosch, Richard B Pollard, Alan Landay, et al.
AIDS Care|July 16, 2014
Commercial lubricant use among HIV-negative men who have sex with men in Los Angeles: implications for the development of rectal microbicides for HIV preventionHeather A Pines, Pamina M Gorbach, Cathy J Reback, et al.
BMC Cancer|June 6, 2026
Early antiretroviral therapy and long-term cancer risk in HIV: 9-year outcomes from the START randomized trialRamya Ramaswami, Jacqueline A Nordwall, Duncan Gilbert, et al.
JAMA|July 20, 2010
Time for oncologists to opt in for routine opt-out HIV testing?Elizabeth Y Chiao, Bruce J Dezube, Susan E Krown, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Current Opinion in HIV and AIDS|March 5, 2013
Curing HIV: lessons from cancer therapyRonald Mitsuyasu
The Journal of Infectious Diseases|May 10, 2002
Immune therapy: non-highly active antiretroviral therapy management of human immunodeficiency virus-infected patientsRonald Mitsuyasu
Current Opinion in Oncology|July 16, 2011
HIV-associated multicentric Castleman diseaseDeepa Reddy, Ronald Mitsuyasu
Current Opinion in HIV and AIDS|October 28, 2010
Cancer biomarkers in HIV patientsRichard F Ambinder, Kishor Bhatia, Otoniel Martinez-Maza, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2004
Anemia in HIV infection: clinical impact and evidence-based management strategiesPaul A Volberding, Alexandra M Levine, Douglas Dieterich, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 5, 2011
A randomized trial of interleukin-2 during withdrawal of antiretroviral treatmentRonald J Bosch, Richard B Pollard, Alan Landay, et al.
AIDS Research and Therapy|August 7, 2010
Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG Protocol A5051, a rollover trial of ACTG Protocol A328)Ronald J Bosch, Richard B Pollard, Alan Landay, et al.
AIDS Care|July 16, 2014
Commercial lubricant use among HIV-negative men who have sex with men in Los Angeles: implications for the development of rectal microbicides for HIV preventionHeather A Pines, Pamina M Gorbach, Cathy J Reback, et al.
BMC Cancer|June 6, 2026
Early antiretroviral therapy and long-term cancer risk in HIV: 9-year outcomes from the START randomized trialRamya Ramaswami, Jacqueline A Nordwall, Duncan Gilbert, et al.
JAMA|July 20, 2010
Time for oncologists to opt in for routine opt-out HIV testing?Elizabeth Y Chiao, Bruce J Dezube, Susan E Krown, et al.
Pageof 5